
    
      Primary Study Objective:

      The study's primary objective is to assess the efficacy of the Medi-Tate iTind in subjects
      with symptomatic BPH by reduction of IPSS) (International Prostate Symptoms Score) score.

      Secondary Study Objectives:

        -  To further evaluate the efficacy of Medi-Tate iTind as determined by increase of maximal
           urinary peak flow, satisfaction from the device and procedures, sex performance
           capabilities and ejaculation.

        -  Safety will be assessed by the rate of complications attributed to the Medi-Tate iTind
           and its implantation/retrieval procedures.
    
  